$JAGX News Article - Jaguar Health Announces Topline Results of Investigator-Initiated Phase 2 Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients https://marketwirenews.com/news-releases/jagu...97846.html